Johnson & Johnson (J&J) has made significant strides in multiple myeloma treatment, with breakthroughs in targeted therapies ...

A treatment approach harnessing bispecific antibodies to target cancerous cells unlocks new possibilities for patients, says ...

Due to the high likelihood of relapse or progression to multiple myeloma, the guidelines now recommend use of the imaging ...

Cancer.net: “Multiple Myeloma: Symptoms and Signs.” National Health Service (U.K.): “Symptoms: Multiple myeloma.” It's challenging to stay on top of treatments, appointments, and day-to ...

Multiple myeloma is considered to be relapsed if it responds positively when you first get treatment, but then starts growing again. Or there might be other signs your initial treatment’s ...

Cesar Rodriguez, MD, discussed several key aspects of talquetamab use in the treatment of relapsed/refractory multiple ...

A ground breaking study mapping the immune microenvironment in Multiple Myeloma identifies critical immune changes and ...

But there is a possibility for prolonged remission. - which begins after treatment when you don’t have multiple myeloma signs ...

Janssen has submitted a new combination regimen for its blockbuster multiple myeloma drug Darzalex for ... and shows no signs of slowing down, growing another 49% to reach $937 million in the ...

The simple lifestyle tweaks you should make to improve your memory Four signs to look out for in your walk that could mean you have dementia ... This disease is sometimes referred to as multiple ...

BioLineRx Ltd. (BLRX) a commercial-stage biopharmaceutical company enters into a license agreement to develop and commercialize ...